Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119291) titled 'This is an Intervention Study to Compare Two Clozapine 100 mg Tablets in Adult Patients with Schizophrenia to compare the blood absorption' on Oct. 9.

Study Type: BA/BE

Study Design: Randomized, Crossover Trial Method of generating randomization sequence:Permuted block randomization, fixed Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Zenara pharma private Limited

Condition: Health Condition 1: F209- Schizophrenia, unspecified

Intervention: Intervention1: Clozapine 100mg Tablets: Test Product: Clozapine 100 mg Tablets manufactured by Zenara Pharma P...